Improving the biomarker pipeline for early cancer detection

Jul 02, 2009

Several statistical and biological issues need to be addressed in order to improve biomarker identification for early detection of cancer, according to a commentary published online July 2 in the Journal of the National Cancer Institute.

The biomarker pipeline to develop and evaluate cancer screening tests includes the identification of promising biomarkers to detect cancers early and the initial and definitive evaluation of biomarkers for cancer screening.

In the commentary, Stuart G. Baker, ScD, of the National Cancer Institute in Bethesda, Md., discusses the various ways to improve this pipeline, including the need for more frequent specimen collection to help identify promising biomarkers and the use of the paired availability design, in which data are collected on the number of interval cases associated with screening in time periods before and after the introduction of the new biomarker test.

"…[S]ome important design and analysis considerations related to this biomarker pipeline have been underappreciated, insufficiently disseminated, or not previously discussed," the author writes. "By taking these considerations into account, researchers can improve this pipeline."

Source: Journal of the National Institute (news : web)

Explore further: Anal, throat cancers on the rise among young adults, study finds

add to favorites email to friend print save as pdf

Related Stories

A faster, simpler test for disease biomarkers

Dec 17, 2007

In an advance toward earlier diagnosis of cancer and other disorders, scientists are reporting development of a potentially fast, simple and inexpensive blood test to detect disease “biomarkers.” The study is scheduled ...

Recommended for you

Clearing cells to prevent cervical cancer

3 hours ago

A study published online in the International Journal of Cancer earlier this month describes a novel approach to preventing cervical cancer based on findings showing successful reduction in the risk of cervical cancer after ...

Is Europe putting cancer research at risk?

7 hours ago

The European Society for Medical Oncology (ESMO), the leading pan-European association representing medical oncology professionals, has expressed concern that the proposed EU General Data Protection Regulation could make ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

E_L_Earnhardt
not rated yet Jul 02, 2009
Applaud your work, but a person with cancer hardly cares whether you get the word, or not. Ask the doctors to help - especially if they arrest the disease! THEN the bio-markers are VITAL! An untouched source are the MINISTERS! ORGANIZE THEM!